Physician profile
Amy G Howard
NPI 1588986319
$1,804.44
in general payments reported to CMS, 2019-2025
12 companies · $751 in 2025
The $751 reported for 2025 was more than what 83% of Acute Care (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $192 · 2022: $21.78 · 2023: $195 · 2024: $644 · 2025: $751.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,590.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,590.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $379.92 | 2021-2025 | Thoratec Heartmate 3 Lvas Implant Kit, Cardiomems |
| Astrazeneca Pharmaceuticals LP | $341.43 | 2024-2025 | Farxiga |
| Abiomed | $223.64 | 2021-2024 | Impella |
| Cvrx, INC. | $222.88 | 2024-2025 | Barostim Neo System |
| Boehringer Ingelheim Pharmaceuticals, INC. | $139.55 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $123.75 | 2025 | |
| Alnylam Pharmaceuticals INC. | $108.77 | 2024 | Onpattro |
| Scpharmaceuticals INC. | $89.59 | 2023 | |
| Merck Sharp & Dohme LLC | $83.56 | 2023 | Verquvo |
| Endotronix, INC. | $44.33 | 2025 | Cordella Pulomonary Artery Pressure Sensor |
| Abbvie INC. | $24.75 | 2025 | |
| Impulse Dynamics (USA) INC. | $22.27 | 2023 | Optimizer |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Howard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.